Trendlines Group Ltd. · SGX:42T
Trendlines — The Trendlines Group — Shareholder Meeting (April 2021)
24 slides from Trendlines's shareholder meeting presentation, Apr 22, 2021
Slide 1: Results of the Annual General Meeting held on 22 April 2021
THE TRENDLINES GROUP LTD. (Incorporated in Israel) (Company Registration No. 513970947) RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 22 APRIL 2021 The Board of Directors (the “Board”) of The Trendlines Group Ltd. (the “Company”) wishes to announce that at its Annual General Meeting (the "AGM") held
Slide 2: Resolution 3 Authority to issue new shares
Resolution 3 340,897,819 340,771,996 99.96% 125,823 0.04% Authority to issue new shares Having been re-elected as a Director of the Company, Mr. Stephen Louis Rhodes remains as Co- Chairman of the Board of Directors of the Company and Co- Chief Executive Officer of the Company. (b) Details of partie
Slide 3: The Trendlines Group AGM presentation
The Trendlines Group AGM presentation Steve Rhodes Todd Dollinger Haim Brosh Chair and CEO Chair and CEO Chief Financial Officer 22 April 2021 SGX:42T OTCQX: TRNLY
Slide 4: Legal disclaimer
Legal disclaimer Important notice This presentation is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any securities of The Trendlines Group Ltd. (“Company”) or any of its portfo
Slide 5: Business highlights
Business highlights
Slide 6: 2020 business highlights
2020 business highlights ApiFix Ltd. acquired by 3 companies launched sales despite COVID-19 OrthoPediatrics Corp. Trendlines Agrifood Fund Pte. Ltd. makes 3 investments 3 new medical portfolio companies established, in Israel and Singapore OrthoSpin Ltd. raised US$5 million with Johnson & Johnson a
Slide 7: Portfolio fair value
Portfolio fair value Portfolio fair value with exit proceeds US$ millions 140 Cumulative exit proceeds 120 2020 Portfolio fair value (excluding 12 Singapore 100 consolidated portfolio companies) 80 60 40 20 0 Period ended 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 5
Slide 8: Post 2020 business developments
Post 2020 business developments • Announced plan to seek a dual primary listing and securities offer on the Tel Aviv Stock Exchange • Portfolio company received a non-binding Letter of Intent from a public corporation for the acquisition of the portfolio company • Established new medical company in
Slide 9: Why list on the Tel Aviv Stock Exchange?
Why list on the Tel Aviv Stock Exchange? • Israeli capital market proven attractive for technology companies / substantial institutional investor participation • Listings on both the SGX-ST and TASE provide access to two different equity markets with different trading times and convenience for local
Slide 10: Why raise more capital?
Why raise more capital? 1. Capital for follow-on investments strengthens our model for greater profits. “Following-on is critical – you must press your winners …you are in a brief position of potential advantage. The importance of follow-ons to a fund’s overall returns stands out in publicly availab
Slide 11: Follow-on investments increase profits
Follow-on investments increase profits • As “insider” investors, we are informed investors • Reduces dilution • Signals commitment to potential co-investors • Faster round completion – management focused on the business • Greater pre-inflection investment at low valuations 9
Slide 12: Pre-inflection investing
Pre-inflection investing Valuation Risk mitigated Highest returns Lowest valuation The Flat Concept: 500 Startups Time 10
Slide 13: Value of Trendlines' Holding
Follow-on investment for greater profit: modeling ApiFix Value of Trendlines’ Holding Trendlines’ cash investment Investment – US$430,000 Exit proceeds – US$14.5M Missed Investment Trendlines’ investment Investment US$350k + missed investment US$600k Investment missed – US$1.6M Missed Estimated tota
Slide 14: Meniscus repair system
Meniscus repair system An all-suture, knotless meniscus repair system Achievements Founded 2013 • FDA and CE regulatory approvals • Sales and distribution in the US, Latin America, CEO Lee Ranon and APAC countries IP U.S. and Chinese patents Funding ~US$7.9 million Investors Strategic and Private in
Slide 15: Robotic external fixation with real-time feedback
Robotic external fixation with real-time feedback Robotic external fixation system allows real-time physician follow-up and reduces dependency on patient compliance. Founded 2014 Achievements CEO Oren Cohen • Successful FIH in US and Israel Chair Assaf Dekel, MD • Received FDA clearance IP 1 Nationa
Slide 16: The natural food color revolution
The natural food color revolution A broad-spectrum of healthy plant-based colors produced via fermentation technology, using yeast as a biofactory. Phytolon’s high-quality and cost-effective pigments offer value for consumers, the environment, and the food industry. Founded 2018 CEO Halim Jubran, Ph
Slide 17: Aquaculture health via oral drug delivery
Aquaculture health via oral drug delivery Proprietary, orally administered particles delivered via feed for enhanced shrimp health, preventing viral endemics from spreading. Future platform expansion for fish vaccines. Achievements Founded 2014 • 2019: Efficacy at a competitive cost demonstrated rep
Slide 18: Financial highlights
Financial highlights
Slide 19: Balance sheet: December 2020
Balance sheet: 31 December 2020 ASSETS US$'000 LIABILITIES US$'000 Current assets Current liabilities Cash and cash equivalents 10,656 Lease liability 669 Short-term bank deposits 101 Trade and other payables 1,679 Accounts and other receivables 2,698 Deferred revenues 616 2,964 Short-term loans to
Slide 20: Consolidated condensed report of income
Consolidated condensed report of income CONSOLIDATED STATEMENTS OF PROFIT OR LOSS U.S. dollars in thousands Full year ended 31 December 2020 2019 Income Gain/Loss from change in fair value of investments in Portfolio (10,996) 3,753 Companies Income from services to Portfolio Companies 2,981 4,821 In
Slide 21: Consolidated condensed report of income
Consolidated condensed report of income CONSOLIDATED STATEMENTS OF PROFIT OR LOSS U.S. dollars in thousands Full year ended 31 December 2020 2019 Expenses Operating, general and administrative expenses 7,937 7,062 Marketing expenses 214 269 R&D expenses, net 1,087 1,114 Financial expenses 860 1,240
Slide 22: SGX: 42T OTCQX: TRNLY www.trendlines.com
SGX: 42T Steve Rhodes, Chair & CEO OTCQX: TRNLY steve@trendlines.com Todd Dollinger, Chair & CEO +972.72.260.7000 todd@trendlines.com www.trendlines.com Haim Brosh, Chief Financial Officer haim@trendlines.com April 2021
Slide 23: Annual General Meeting SGX announcement
REPL::ANNUAL GENERAL MEETING::VOLUNTARY Issuer & Securities Issuer/ Manager THE TRENDLINES GROUP LTD. Security THE TRENDLINES GROUP LTD. - IL0011328858 - 42T Announcement Details Announcement Title Annual General Meeting Date &Time of Broadcast 22-Apr-2021 17:48:42 Status Replacement Announcement Re
Slide 24: Meeting venue and attachments
Place Venue(s) Venue details Meeting The Annual General Meeting will be held by electronic means. Therefore shareholders will Venue not be able to attend the Annual General Meeting in person. Attachments 1. AGM Results_22 April 2021.pdf 2. Trendlines AGM 2021 PPT_FINAL.pdf Total size =1253K MB Relat
The Trendlines Group — Shareholder Meeting (April 2021) on 6ix